About Alex Melamed, MD

Alexander “Alex” Melamed, MD, is a gynecologic oncologist who provides surgical care and chemotherapy to patients with cancers of the female reproductive system such as ovarian, uterine, cervical, and vulvar cancers. His goal as a physician is to get to get to know every patient as a whole person. He wants to know about your family, your pets, your work, how you like to spend your time, what you are all about, and what matters to you so that you can work together to develop a treatment plan that is consistent with your goals and values. He is proud to practice at one of the world’s top hospitals, where he gets to be part of a large and dedicated team focused on delivering the state-of-the-art patient-centered cancer care. 

In addition to caring for patients he is also a cancer researcher focused on understanding exactly what kind of cancer treatments work best for patients. Some of his research has influenced how gynecologic oncologists treat cervical and ovarian cancer and has been published in important medical journals, like the New England Journal of Medicine, JAMA, and Journal of Clinical Oncology.

Dr. Melamed was born in Kyiv, Ukraine, and grew up in the US. He majored in chemical biology at the University of California at Berkeley and studied medicine and public health at the University of Southern California. He completed residency in Obstetrics and Gynecology and a fellowship in gynecologic oncology at Brigham and Women’s Hospital and Massachusetts General Hospital. 

When he is not working, he enjoys playing with his toddler son, preschooler daughter, and 6-year-old puppy.  He enjoys cooking, playing guitar, and listening to live music.

Clinical Interests:




Massachusetts General Hospital
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2000

Medical Education

  • MD, USC Keck School of Medicine
  • Residency, Brigham and Women's Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Gynecologic Oncology, American Board of Obstetrics and Gynecology
  • Obstetrics & Gynecology, American Board of Obstetrics and Gynecology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


My research focuses on increasing understanding of how surgical care impacts the lives of cancer patients. I am interested in methods that allow researchers to draw meaningful insights from observational data. My work explores how focusing on temporal and spatial variation in practice can help to uncover how cancer treatments affect patient outcomes.

Click Here


  • Cham S, Li A, Rauh-Hain JA, Tergas AI, Hershman DL, Wright JD, Melamed A. Association Between Neighborhood Socioeconomic Inequality and Cervical Cancer Incidence Rates in New York City. JAMA Oncol. 2022;8(1):159-161.

    Melamed A, Rauh-Hain JA, Gockely AA, Ramirez PT, Heshman DL, Keating NK, Wright JD. Association between overall survival and the tendency for cancer programs to administer neoadjuvant chemotherapy for patients with advanced ovarian cancer. JAMA Oncol. 2021;7(12):1782-1790.

    Emeruwa UN, Ona S, Shaman JL, Turitz A, Wright JD, Gyamfi-Bannerman C, Melamed A. Associations Between Built Environment, Neighborhood Socioeconomic Status, and SARS-CoV-2 Infection Among Pregnant Women in New York City. JAMA. 2020;324(4):390-392.

    Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, Seagle BL, Alexander A, Barber EL, Rice LW, Wright JD, Kocherginsky M, Shahabi S, Rauh-Hain JA. Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. N Engl J Med. 2018;379(20):1905-1914

    Melamed A, Fink G, Wright AA, Keating NL, Gockley AA, Del Carmen MG, Schorge JO, Rauh-Hain JA. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study. BMJ. 2018;360:j5463

    Click Here

Reviews: Comments and Ratings